Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP749219.RAOExwnr2I6nWm_GVX0nrwBulDPmyVxPrPRtyXYC3UJRs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP749219.RAOExwnr2I6nWm_GVX0nrwBulDPmyVxPrPRtyXYC3UJRs130_assertion type Assertion NP749219.RAOExwnr2I6nWm_GVX0nrwBulDPmyVxPrPRtyXYC3UJRs130_head.
- NP749219.RAOExwnr2I6nWm_GVX0nrwBulDPmyVxPrPRtyXYC3UJRs130_assertion description "[By multivariate analysis, a low CD3(+)/FoxP3(+) cell ratio (P= .0318) and low numbers of CD3(+) T cells (P = .0397) predicted shorter DFS times and were stronger prognostic variables than tumor stage or number of lymph node metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP749219.RAOExwnr2I6nWm_GVX0nrwBulDPmyVxPrPRtyXYC3UJRs130_provenance.
- NP749219.RAOExwnr2I6nWm_GVX0nrwBulDPmyVxPrPRtyXYC3UJRs130_assertion evidence source_evidence_literature NP749219.RAOExwnr2I6nWm_GVX0nrwBulDPmyVxPrPRtyXYC3UJRs130_provenance.
- NP749219.RAOExwnr2I6nWm_GVX0nrwBulDPmyVxPrPRtyXYC3UJRs130_assertion SIO_000772 19577568 NP749219.RAOExwnr2I6nWm_GVX0nrwBulDPmyVxPrPRtyXYC3UJRs130_provenance.
- NP749219.RAOExwnr2I6nWm_GVX0nrwBulDPmyVxPrPRtyXYC3UJRs130_assertion wasDerivedFrom befree-2016 NP749219.RAOExwnr2I6nWm_GVX0nrwBulDPmyVxPrPRtyXYC3UJRs130_provenance.
- NP749219.RAOExwnr2I6nWm_GVX0nrwBulDPmyVxPrPRtyXYC3UJRs130_assertion wasGeneratedBy ECO_0000203 NP749219.RAOExwnr2I6nWm_GVX0nrwBulDPmyVxPrPRtyXYC3UJRs130_provenance.